![](https://www.diabetesnews.com/wp-content/uploads/2016/09/Insulin_Nation_Do_You_Need_More_TCells_shutterstock_439844257_945px-825x510-150x150.jpg)
A novel treatment meant to stop Type 1 diabetes by increasing the number of T cells in the body is being given special attention by the FDA. The treatment, called CLBS03, has recently been granted Fast Track status by federal regulators, a designation which speeds up the approval process.